GIACOPPO, DANIELE
 Distribuzione geografica
Continente #
AS - Asia 1.204
NA - Nord America 1.168
EU - Europa 467
SA - Sud America 152
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.016
Nazione #
US - Stati Uniti d'America 1.138
CN - Cina 480
SG - Singapore 464
IT - Italia 268
KR - Corea 177
BR - Brasile 139
UA - Ucraina 58
IE - Irlanda 44
RU - Federazione Russa 26
HK - Hong Kong 24
CA - Canada 23
CI - Costa d'Avorio 16
VN - Vietnam 14
IN - India 13
NL - Olanda 11
AT - Austria 10
FI - Finlandia 10
BD - Bangladesh 9
AR - Argentina 8
GB - Regno Unito 7
ES - Italia 6
TR - Turchia 6
DE - Germania 5
MX - Messico 4
ZA - Sudafrica 4
AZ - Azerbaigian 3
BY - Bielorussia 3
CH - Svizzera 3
PL - Polonia 3
SE - Svezia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
BG - Bulgaria 2
FR - Francia 2
IQ - Iraq 2
JM - Giamaica 2
MA - Marocco 2
PH - Filippine 2
AL - Albania 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
GR - Grecia 1
HN - Honduras 1
JO - Giordania 1
JP - Giappone 1
KE - Kenya 1
LB - Libano 1
MK - Macedonia 1
OM - Oman 1
PK - Pakistan 1
SA - Arabia Saudita 1
SN - Senegal 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.016
Città #
Santa Clara 430
Hefei 333
Singapore 268
Seoul 177
Civitanova Marche 120
Chicago 98
Dallas 86
Boardman 73
Jacksonville 64
Dublin 44
Catania 38
Ashburn 36
Chandler 32
Los Angeles 25
Hong Kong 24
Milan 24
Nanjing 21
São Paulo 18
Beijing 17
Abidjan 16
Andover 13
Rome 13
Cambridge 12
Lawrence 12
Toronto 12
Palermo 11
Brooklyn 8
Moscow 8
San Mateo 8
San Francisco 7
Wilmington 7
Lappeenranta 6
Ottawa 6
Phoenix 6
Chennai 5
Des Moines 5
Hebei 5
Jiaxing 5
Shenyang 5
Bernareggio 4
Boston 4
Dong Ket 4
Helsinki 4
Nanchang 4
Naples 4
Rio de Janeiro 4
Washington 4
Agerola 3
Amsterdam 3
Baku 3
Barcelona 3
Bari 3
Council Bluffs 3
Curitiba 3
Houston 3
Itaquaquecetuba 3
London 3
Mexico City 3
Minsk 3
Norwalk 3
Porto Alegre 3
Salzburg 3
Sorocaba 3
Tessennano 3
Tianjin 3
Turin 3
Vienna 3
Villafranca Padovana 3
Warsaw 3
Ankara 2
Brasília 2
Brussels 2
Buffalo 2
Campinas 2
Can Tho 2
Cape Town 2
Charlotte 2
Contagem 2
Dhaka 2
Diadema 2
Florence 2
Ho Chi Minh City 2
Honolulu 2
Istanbul 2
Kingston 2
Marabá 2
Mascalucia 2
New York 2
Omsk 2
Quezon City 2
Recife 2
Salvador 2
San Juan 2
St Petersburg 2
Thái Nguyên 2
Votorantim 2
Zugliano 2
Zurich 2
Agordo 1
Almirante Tamandaré 1
Totale 2.256
Nome #
Temporal patterns of early neointimal strut coverage of the CATANIA stent compared with drug eluting stents and bare metal stent: the Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 86
Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography in the Guidance of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis. 83
Pharmacological and Clinical Appraisal of Factor XI Inhibitor Drugs. 81
Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke : JACC State-of-the-Art Review 79
Spontaneous coronary artery dissection 70
Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry) 68
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients. 63
Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality? 63
Safety and effectiveness of the Catania Polyzene-F coated stent in real world clinical practice: 12-month results from the ATLANTA 2 registry 61
Mid-term clinical outcome of Catania coronary stent system with nanothin Polyzene-F in a real world unselected population: preliminary results 60
PCSK9 inhibitors: current status and emerging frontiers in lipid control 58
Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence from a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients 58
Short and mid-term benefits of coronary stent system with nanothin Polyzene-F in acute coronary syndromes: preliminary result 55
Usefulness of the logistic clinical SYNTAX score for predicting 1-year mortality in patients undergoing percutaneous coronary intervention of the left main coronary artery 53
Mid-term clinical outcome of CATANIA Coronary stent system with nanothin Polyzene-F in a real world unselected population: preliminary results 51
Association between surgical risk and 30‐day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta‐analysis. 50
Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention. 49
Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis 48
Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial 48
Five‐year follow‐up of polymer‐free sirolimus‐ and probucol‐eluting stents versus new generation zotarolimus‐eluting stents in patients presenting with st‐elevation myocardial infarction 47
Characteristics and Impact of Randomized Trials on Drugs or Devices in Cardiovascular Medicine 47
Meta-analysis of Randomized Controlled Trials of Preprocedural Statin Administration for Reducing Contrast Induced Acute Kidney In Patients Undergoing Coronary Catheterization 47
Current developments in dual antiplatelet therapy after stenting 46
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology. 46
Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial. 45
Evaluation of a Low-Dose Radiation Protocol During Transcatheter Aortic Valve Implantation 45
Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis. 45
Anticoagulation After Transcatheter Aortic Valve Replacement 45
Safety and efficacy of minimalist transcatheter aortic valve implantation using a new-generation balloon-expandable transcatheter heart valve in bicuspid and tricuspid aortic valves. 45
Coronary Drug-Coated Balloons for De Novo and In-Stent Restenosis Indications. 44
Do outcomes following intervention for drug-eluting stent restenosis depend on whether the restenosed stent was polymer-free or polymer-coated? 43
Effects on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: Meta-Analysis of Individual Patient Data From 7 Multicenter Randomized Clinical Trials. 43
Intraindividual Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Drug-Eluting Metallic Stents 42
Changes in high-sensitivity troponin after drug-coated balloon angioplasty for drug-eluting stent restenosis. 42
Meta-Analysis of Short vs. Prolonged Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation and Role of Continuation with either Aspirin or a P2Y12 Inhibitor Thereafter 41
Management of in-stent restenosis 40
Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study). 40
Transcatheter versus surgical aortic valve replacement in the digital era: Meta‐analysis based on the reconstruction of time‐to‐event individual patient data. 39
Optimal periprocedural antithrombotic therapy in percutaneous coronary intervention: Between a rock and a hard place? 38
Vascular response to percutaneous coronary intervention with biodegradable-polymer vs. new-generation durable-polymer drug-eluting stents: a meta-analysis of optical coherence tomography imaging trials 38
Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects 38
The Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 38
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis. 38
Acute kidney injury after endovascular interventions for critical limb ischemia: Is that a whole different animal? 38
Management of myocardial revascularisation failure: an expert consensus document of the EAPCI 36
Risk of stroke, atrial fibrillation, and major bleeding after mitral valve repair: the jury is still out. 36
Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis. 36
Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis. 35
Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials 35
Prognostic Value of Cardiac Troponin T and Sex in Patients Undergoing Elective Percutaneous Coronary Intervention 34
Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents. 33
Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trials 31
Drug-Coated Balloon Versus Plain Balloon Angioplasty for the Treatment of Femoropopliteal Artery Disease. 30
Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials. 30
Angiographic and clinical outcomes of patients treated with drug-coated balloon angioplasty for in-stent restenosis after coronary bifurcation stenting with a two-stent technique. 30
Response by Giacoppo et al to Letter Regarding Article “Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis” 28
A pairwise and network meta-analysis of anti-inflammatory strategies after myocardial infarction: the TITIAN study 25
Long-term effectiveness and safety of transcatheter closure of patent foramen ovale compared with antithrombotic therapy alone: a meta-analysis of six randomised clinical trials and 3,560 patients with reconstructed time-to-event data 25
Koronare Herzerkrankung mit Hauptstammbeteiliung 24
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents. 24
Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention 23
Current Management of In-Stent Restenosis 23
Changes in Coagulation Factor XI Activity Levels in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI 23
P2Y 12 inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials 22
Dual antiplatelet therapy de-escalation by discontinuation in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis 22
Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry 22
Radial artery access among mainstays of contemporary percutaneous coronary intervention: Is it time to forget how to puncture a femoral artery? 20
Molecular multimodality imaging: has a long-standing dream come true? 19
Impact of bystander-initiated cardiopulmonary resuscitation for out-of-hospital cardiac arrest: where would you be happy to have a cardiac arrest? 19
Trends in transcatheter aortic valve implantation practice and clinical outcomes at an Irish tertiary referral centre 17
Paclitaxel- or sirolimus-coated balloons for coronary bifurcations: is the side branch SPACIOUS enough for both? 17
One-month DAPT after biodegradable-polymer everolimus-eluting stent implantation in patients at high-bleeding risk: an individual patient data pooled analysis of the SENIOR and POEM trials 16
Untangling the knot of the best endovascular treatment for femoropopliteal artery disease 16
Predicting the risk of in-stent restenosis after drug-eluting stent implantation: Pipe dream or machine learning-enabled opportunity? 15
Management of Patients Treated With Oral Anticoagulant Therapy Undergoing Percutaneous Coronary Intervention With Stent Implantation: The PERSEO Registry 15
Completeness, timing, and guidance of percutaneous coronary intervention for myocardial infarction and multivessel disease: a systematic review and network meta-analysis 14
Off TARGET Effects in Stent Comparison Trials 12
Gli stent coronarici a rilascio di farmaco nella pratica interventistica contemporanea: progetto STENT PANORAMA (Parte I) 11
Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA study 10
Long-Term Antithrombotic Therapy in Patients with Atrial Fibrillation and Percutaneous Coronary Intervention 10
Expanding indications for drug-coated balloons in coronary artery disease 9
Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial 9
High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction deemed not suitable for surgical revascularisation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the ESC Working Group on Cardiovascular Surgery 8
Reply: Completeness or complexity? A nuanced reflection on multivessel revascularisation 5
Totale 3.113
Categoria #
all - tutte 11.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202170 0 0 12 1 21 0 12 0 8 0 12 4
2021/202290 12 13 1 0 16 0 13 6 10 0 2 17
2022/2023127 12 1 1 9 20 21 0 18 40 1 0 4
2023/2024246 1 14 4 14 1 10 0 70 12 14 63 43
2024/20251.483 16 174 53 137 328 200 72 30 99 105 92 177
2025/2026974 350 595 29 0 0 0 0 0 0 0 0 0
Totale 3.113